isabelobrien, Author at European Medical Journal - Page 11 of 65

Mangrove tree

Award spotlights role of genomics in conservation

While genomics is best known for its role advancing precision medicine, MGI Tech has pioneered a new use case in enviromental sustainability.

HIV ribbon

UNAIDS: AIDS response at risk from funding cuts

UNAIDS report warns the US funding collapse could risk millions of new infections and deaths unless countries transform their HIV responses.

Claudio Cerchione

Hema Now: Episode 21: Global Perspectives on Myeloma

Claudio Cerchione explores advances in multiple myeloma, MRD, and CAR-T therapy, with key insights from EHA and ASCO in this Hema Now episode.

Swimming pool

Sanofi returns as sponsor of British Transplant Games

Sanofi is sponsoring the event for the second year in a row, which brings together 1,000 transplant recipients and live donors to compete.

Pharma seized the spotlight at Cannes Lions – here's why

In a departure from years past, Cannes Lions 2025 saved a sizable percentage of their praise for companies in the pharma space.

Illustration of scientific tools

New report calls for faster R&D for rare diseases

A report has found that while many in the UK live with rare diseases, systemic failures continue to restrict progress in treatment.

GSK’s Matt Mortimer-Ryan on behaviour-led pharma marketing

Matt Mortimer Ryan, GSK, discusses how understanding patients’ emotional drivers can unlock more impactful pharma marketing campaigns.

Onima Chowdhury and Kevin Rouault-Pierre

Hema Now: Episode 20: The Science Behind Myelodysplastic Syndromes

Kevin Rouault-Pierre and Onima Chowdhury explore the molecular roots of myelodysplastic syndromes (MDS), and their implications for future care.

Spoonful of technology: April-June 2025

Explore the latest technology that is changing the pharma industry, and discover how these innovations could solve key health challenges.

The word spotlight on a blue background with the 'o' as a spotlight circle

Spotlight: June 2025

From new industry M&As to insights on how to recruit Gen Z talent, there’s plenty to discover in our latest pharma news round up.